{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:04:22Z","timestamp":1792649062490,"version":"4.5.0"},"reference-count":113,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.critrevonc.2021.103529","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T11:48:19Z","timestamp":1637149699000},"page":"103529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications"],"prefix":"10.1016","volume":"168","author":[{"given":"Ming Sheng","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Mcrae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2021.103529_bib0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09801-x","article-title":"Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome","volume":"10","author":"Ali","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0015","first-page":"71","article-title":"Interaction between the coagulation and complement system","volume":"632","author":"Amara","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0020","article-title":"Presence of antiphospholipid antibodies in COVID-19: case series study","author":"Amezcua-Guerra","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0025","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1161\/ATVBAHA.120.314872","article-title":"Prevalence and outcomes of D-Dimer elevation in hospitalized patients with COVID-19","volume":"40","author":"Berger","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0030","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1056\/NEJMcp2009575","article-title":"Severe Covid-19","volume":"383","author":"Berlin","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0035","first-page":"1953","article-title":"Anticardiolipin IgG autoantibody level is an independent risk factor for COVID-19 severity","volume":"72","author":"Bertin","year":"2020","journal-title":"."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0040","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-Art review","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0045","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1055\/s-0040-1713152","article-title":"Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research","volume":"120","author":"Bikdeli","year":"2020","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41591-020-01202-8","article-title":"Immune determinants of COVID-19 disease presentation and severity","volume":"27","author":"Brodin","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00550","article-title":"A role for neutrophils in viral respiratory disease","volume":"8","author":"Camp","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0060","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2014.5990","article-title":"Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage","volume":"311","author":"Chatterjee","year":"2014","journal-title":"JAMA."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0065","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019, J. Clin","volume":"130","author":"Chen","year":"2020","journal-title":"Invest."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.avsg.2020.08.087","article-title":"Arterial Thrombosis in Coronavirus Disease 2019 Patients: A Rapid Systematic Review","volume":"70","author":"Cheruiyot","year":"2020","journal-title":"Ann. Vasc. Surg."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0075","author":"Ciceri"},{"key":"10.1016\/j.critrevonc.2021.103529_bib0080","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","article-title":"SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2","volume":"183","author":"Clausen","year":"2020","journal-title":"Cell."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0085","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14893","article-title":"Coagulopathy of COVID-19 and antiphospholipid antibodies","author":"Connell","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0090","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0095","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/jth.14994","article-title":"Antiphospholipid antibodies in patients with COVID-19: A relevant observation?","volume":"18","author":"Devreese","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0100","first-page":"4040","article-title":"Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience","volume":"24","author":"Diurno","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0105","doi-asserted-by":"crossref","DOI":"10.1111\/cei.13497","article-title":"MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti-MASP2 antibody narsoplimab","volume":"203","author":"Elhadad","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0110","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1128\/JVI.79.17.11062-11070.2005","article-title":"Dipyridamole reversibly inhibits mengovirus RNA replication","volume":"79","author":"Fata-Hartley","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0115","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-03273-y","article-title":"Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: implications for clinical practice and future investigations","volume":"24","author":"Flaczyk","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.critrevonc.2021.103529_bib0120","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.306853","article-title":"Cross talk pathways between coagulation and inflammation","volume":"118","author":"Foley","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01518","article-title":"Targeting the NLRP3 inflammasome in severe COVID-19","volume":"11","author":"Freeman","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0130","article-title":"Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation","author":"Gao","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.critrevonc.2021.103529_bib0135","first-page":"754","article-title":"Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases","volume":"38","author":"Gatto","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0140","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0145","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1172\/JCI110898","article-title":"Mechanisms of activation of the classical pathway of complement by Hageman factor fragment","volume":"71","author":"Ghebrehiwet","year":"1983","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0150","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0140-6736(98)07534-5","article-title":"Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)","volume":"353","author":"Goldhaber","year":"1999","journal-title":"Lancet (London, England)."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0155","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0160","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00271-13","article-title":"Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury","volume":"4","author":"Gralinski","year":"2013","journal-title":"MBio."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0165","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01753-18","article-title":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","volume":"9","author":"Gralinski","year":"2018","journal-title":"MBio."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0170","article-title":"Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: a systematic review and meta-analysis","author":"Gungor","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0175","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/ajh.25982","article-title":"Thrombosis in COVID-19","volume":"95","author":"Hanff","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0180","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1097\/00003246-199012000-00021","article-title":"Prevention of adult respiratory distress syndrome with plasminogen activator in pigs","volume":"18","author":"Hardaway","year":"1990","journal-title":"Crit. Care Med."},{"issue":"April(4)","key":"10.1016\/j.critrevonc.2021.103529_bib0185","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/000313480106700417","article-title":"Treatment of severe acute respiratory distress syndrome: a final report on a phase I study - PubMed","volume":"67","author":"Hardaway","year":"2001","journal-title":"Am. Surg."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0190","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1111\/jth.14867","article-title":"Lupus anticoagulant is frequent in patients with Covid-19","volume":"18","author":"Harzallah","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0195","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0200","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1515\/cclm-2020-0369","article-title":"Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis","volume":"58","author":"Henry","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0205","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.2020007252","article-title":"Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19","volume":"136","author":"Hottz","year":"2020","journal-title":"Blood."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0210","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1097\/ALN.0000000000003122","article-title":"Sepsis-induced Coagulopathy and Disseminated Intravascular Coagulation","volume":"132","author":"Iba","year":"2020","journal-title":"Anesthesiology."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0215","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-03077-0","article-title":"The unique characteristics of COVID-19 coagulopathy","volume":"24","author":"Iba","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.critrevonc.2021.103529_bib0220","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/CCM.0000000000004458","article-title":"Coagulopathy of coronavirus disease 2019","volume":"48","author":"Iba","year":"2020","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0225","series-title":"Crit. Care Med., Lippincott Williams and Wilkins","article-title":"Coagulation, fibrinolysis, and fibrin deposition in acute lung injury","author":"Idell","year":"2003"},{"key":"10.1016\/j.critrevonc.2021.103529_bib0230","author":"INSPIRATION Investigators","year":"2021","journal-title":"JAMA."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0235","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with Covid-19","volume":"385","author":"Investigators","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0240","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19","volume":"385","author":"Investigators","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0245","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000484257","article-title":"Kallikrein Cleaves C3 and activates complement","volume":"10","author":"Irmscher","year":"2018","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0250","doi-asserted-by":"crossref","DOI":"10.1038\/s41426-018-0063-8","article-title":"Blockade of the C5a-C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV article","volume":"7","author":"Jiang","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0255","first-page":"e276","article-title":"COVID-19 and multisystem inflammatory syndrome in children and adolescents, Lancet Infect","volume":"20","author":"Jiang","year":"2020","journal-title":"Dis."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph13080166","article-title":"Immune pathogenesis of covid-19 intoxication: Storm or silence?","volume":"13","author":"Kiselevskiy","year":"2020","journal-title":"Pharmaceuticals."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0265","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0270","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/rth2.12397","article-title":"Potential role of platelets in COVID\u201019: implications for thrombosis","volume":"4","author":"Koupenova","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0275","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCRESAHA.117.310795","article-title":"Circulating platelets as mediators of immunity, inflammation, and thrombosis","volume":"122","author":"Koupenova","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0280","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jama.2020.17052","article-title":"Cytokine levels in critically ill patients with COVID-19 and other conditions","volume":"324","author":"Kox","year":"2020","journal-title":"JAMA - J. Am. Med. Assoc."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0285","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0038-1677040","article-title":"Neutrophil extracellular traps in arterial and venous thrombosis","volume":"45","author":"Laridan","year":"2019","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0290","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1055\/s-0040-1710006","article-title":"Platelets in coronavirus disease 2019","volume":"46","author":"Larsen","year":"2020","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0295","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/M20-2566","article-title":"Pulmonary arterial thrombosis in COVID-19 with fatal outcome\u202f: results from a prospective, single-center, clinicopathologic case series","volume":"173","author":"Lax","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0300","article-title":"Coagulation dysfunction in COVID-19: the interplay between inflammation, viral infection and the coagulation system","author":"Lazzaroni","year":"2020","journal-title":"Blood Rev."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102925","article-title":"Vascular occlusion by neutrophil extracellular traps in COVID-19","volume":"58","author":"Leppkes","year":"2020","journal-title":"EBioMedicine."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0310","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/rth2.12400","article-title":"Thrombosis and coagulopathy in COVID\u201019: an illustrated review","volume":"4","author":"Levi","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0315","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0320","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1055\/s-0040-1709650","article-title":"D-dimer is associated with severity of coronavirus disease 2019: a pooled analysis","volume":"120","author":"Lippi","year":"2020","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0325","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis","volume":"506","author":"Lippi","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.critrevonc.2021.103529_bib0330","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.apsb.2020.04.008","article-title":"Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19","volume":"10","author":"Liu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.critrevonc.2021.103529_bib0335","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1161\/ATVBAHA.120.314514","article-title":"Coagulation abnormalities and thrombosis in patients infected with SARS-CoV-2 and other pandemic viruses","volume":"40","author":"MacKman","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl. Res."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0345","first-page":"29","article-title":"Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis","author":"Malas","year":"2020","journal-title":"EClinicalMedicine."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0350","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"Manne","year":"2020","journal-title":"Blood."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0355","article-title":"COVID-19 infection: viral macro- and micro-vascular coagulopathy and Thromboembolism\/Prophylactic and therapeutic management","volume":"26","author":"Manolis","year":"2020","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0360","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41573-019-0031-6","article-title":"Clinical promise of next-generation complement therapeutics","volume":"18","author":"Mastellos","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0365","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/CIRCRESAHA.120.317447","article-title":"The emerging threat of (Micro)Thrombosis in COVID-19 and its therapeutic implications","volume":"127","author":"McFadyen","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including Interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0375","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1016\/S2665-9913(20)30121-1","article-title":"Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia","volume":"2","author":"McGonagle","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0380","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/jth.14960","article-title":"Fibrinolysis and COVID-19: A plasmin paradox","volume":"18","author":"Medcalf","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0385","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0390","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0395","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0400","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.chest.2020.05.559","article-title":"Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report","volume":"158","author":"Moores","year":"2020","journal-title":"Chest."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0405","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.120.048488","article-title":"Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy","volume":"142","author":"Nicolai","year":"2020","journal-title":"Circulation."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0410","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/rth2.12439","article-title":"Risk of venous thromboembolism in patients with COVID\u201019: a systematic review and meta\u2010analysis","volume":"4","author":"Nopp","year":"2020","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0415","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/jth.15016","article-title":"Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis","volume":"18","author":"Nougier","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0420","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1016\/S2352-3026(20)30215-5","article-title":"Endothelial cells orchestrate COVID-19 coagulopathy","volume":"7","author":"O\u2019Sullivan","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0425","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1111\/j.1538-7836.2006.02065.x","article-title":"Blood platelets activate the classical pathway of human complement","volume":"4","author":"Peerschke","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0430","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.thromres.2020.08.020","article-title":"Venous thromboembolism in patients with COVID-19: systematic review and meta-analysis","volume":"196","author":"Porfidia","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0435","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01608-2020","article-title":"Thrombosis and COVID-19 pneumonia: The clot thickens!","volume":"56","author":"Price","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0440","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/jth.14854","article-title":"The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome, J. Thromb","volume":"18","author":"Ranucci","year":"2020","journal-title":"Haemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0445","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/blood-2016-11-709865","article-title":"HUS and atypical H.U.S","volume":"129","author":"Sakari Jokiranta","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2021.103529_bib0450","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.thromres.2020.07.016","article-title":"Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?","volume":"195","author":"Siguret","year":"2020","journal-title":"Thromb. Res."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0455","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jamainternmed.2020.3313","article-title":"Is a \u201ccytokine storm\u201d relevant to COVID-19?","volume":"180","author":"Sinha","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0460","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/jth.14929","article-title":"Scientific and Standardization Committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19","volume":"18","author":"Spyropoulos","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0465","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0470","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine storm in COVID-19: the current evidence and treatment strategies","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0475","doi-asserted-by":"crossref","first-page":"7441","DOI":"10.4049\/jimmunol.0902497","article-title":"Neutrophils ameliorate lung injury and the development of severe disease during influenza infection","volume":"183","author":"Tate","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0480","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: the vasculature unleashed","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0485","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"Thachil","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0490","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.631139","article-title":"A comprehensive review of viral characteristics, transmission, pathophysiology, immune response, and management of SARS-CoV-2 and COVID-19 as a basis for controlling the pandemic","volume":"12","author":"Triggle","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0495","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1111\/jth.15094","article-title":"Anticoagulant interventions in hospitalized patients with COVID-19: a scoping review of randomized controlled trials and call for international collaboration","volume":"18","author":"Tritschler","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0500","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-03148-2","article-title":"Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence","volume":"24","author":"Van Haren","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.critrevonc.2021.103529_bib0505","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0510","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1016\/S2665-9913(20)30341-6","article-title":"Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial","volume":"2","author":"Vlaar","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0515","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1111\/jth.14828","article-title":"Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series","volume":"18","author":"Wang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0520","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jamcollsurg.2020.05.007","article-title":"Fibrinolysis shutdown correlation with thromboembolic events in severe COVID-19 infection","volume":"231","author":"Wright","year":"2020","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0525","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.41425","article-title":"Antiphospholipid antibodies in critically ill patients with COVID-19","volume":"72","author":"Xiao","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0530","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","article-title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0535","article-title":"Endothelial cell control of thrombosis, BMC Cardiovasc","volume":"15","author":"Yau","year":"2015","journal-title":"Disord."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0540","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/CIRCRESAHA.120.317703","article-title":"Platelets can associate with SARS-CoV-2 RNA and are hyperactivated in COVID-19","volume":"127","author":"Zaid","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0545","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and antiphospholipid antibodies in patients with Covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2021.103529_bib0550","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s11239-020-02182-9","article-title":"Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients","volume":"50","author":"Zhang","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.critrevonc.2021.103529_bib0555","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.critrevonc.2021.103529_bib0560","article-title":"Neutrophil extracellular traps and thrombosis in COVID-19","author":"Zuo","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.critrevonc.2021.103529_bib0565","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd3876","article-title":"Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19","volume":"12","author":"Zuo","year":"2020","journal-title":"Sci. Transl. Med."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842821003164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842821003164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:40:44Z","timestamp":1760902844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842821003164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":113,"alternative-id":["S1040842821003164"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103529","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103529"}}